18hon MSN
CDT1 overexpression suppresses DNA replication and triggers DNA damage linked to cancer, finds study
A research group has demonstrated that overexpression of Cdc10-dependent transcript 1 (CDT1), a key regulator of DNA ...
This infographic explores the fundamental principles of these three major electrophoresis techniques while showcasing their ...
As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...
Ansa Biotechnologies announced the appointment of Geoff Hamilton as Chief Financial Officer and Chief Business Officer.
IFLScience on MSN
Radical New Treatment Clears Disease In 64 Percent Of Patients With Incurable Cancer
P atients with previously incurable cancer are seeing incredible results thanks to a pioneering new treatment that has just ...
Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample ...
In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.
Natera, Inc. , a global leader in cell-free DNA and precision medicine, today shared the results from two oral presentations that were presented at the American Society of Hematology (ASH) Annual ...
18hon MSN
New Research Found Coffee Adds 5 Years to Your Life. But Here's Exactly How Much You Need to Drink.
The findings from a study published in BMJ Mental Health might give you another reason to pour another cup. Scientists have ...
A novel computational tool has been used to identify a metabolic weakness in acute myeloid leukemia, offering a new drug ...
22hon MSN
Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology
Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results